Meredith has helped provide strategic insights and recommendations to pharmaceutical and biotech clients across a wide range of therapeutic areas including, but not limited to, hematology / oncology, neurology, dermatology, and rare diseases.
Her business engagements have also been expansive, including novel development strategy, commercial opportunity, competitive landscape and assessment, pricing strategy, and market access. Prior to joining Putnam in 2016, Meredith earned her BA in economics, with concentrations in finance and international trade, from Dartmouth College.